Madhusudan Narayan, Birajit Mohanty, Mahesh Kumar
Madhusudan Narayan1, Dr. Birajit Mohanty2, Mahesh Kumar1
1Research Scholar, Department of Business Administration, Manipal University Jaipur.
2Associate Professor, Department of Business Administration, Manipal University Jaipur.
Volume - 13,
Issue - 10,
Year - 2020
This research focuses on the marketing promotional tools used by pharmaceutical companies in India and how doctors respond to all these marketing strategies in terms of their prescription behaviour. Simple random sampling method was chosen for selection of samples. Out of a total of 180 questionnaires sent to different cadres of physicians/ doctors in the city of Rajasthan either in person or through e-mail and only 152 responses were received in complete form. The gathered data were processed through SPSS. The detailed analysis of the study revealed that about 62% of doctors admit to being influenced by promotional strategies employed by pharmaceutical companies. Further, irrespective of forms of marketing and drug promotion by pharmaceutical companies, the socioeconomic status of the patient remained a key consideration in the prescription of medication. The results of chi-square test revealed a significant difference in the perception of different cadre of doctors on need for drug presentation as a marketing promotion tool and benefit for attending drug presentation/product launches.
Cite this article:
Madhusudan Narayan, Birajit Mohanty, Mahesh Kumar. Examining the Effect of Marketing Promotional strategies of Pharmaceutical Companies on Doctors’ Prescription Behaviour. Research J. Pharm. and Tech. 2020; 13(10):4888-4894. doi: 10.5958/0974-360X.2020.00860.4
1. Rajagopal, (2007), "Buying decisions towards organic products: an analysis of customer value and brand drivers", International Journal of Emerging Markets, Vol. 2 No. 3, pp. 236-251. https://doi.org/10.1108/17468800710758387
2. Equity Master Report, 2017
3. Landau R, Achilladelis B, Scriabine A. Pharmaceutical Innovation: Revolutionizing Human Health. Chemical Heritage Press, 1999, 100-105.
4. Taneja (2008)
5. Naik AD, Woofter AL, Skinner JM (2009) Pharmaceutical company influence on nonsteroidal anti-inflammatory drug prescribing behaviors. Am J Manag Care 15: e9-e15.
6. Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K (2010) Factors influencing primary care physicians to prescribe antibiotics in Delhi India. Fam Pract 27: 684-690.
7. Lieb and Scheurich (2014) Contact between Doctors and the Pharmaceutical Industry, Their Perceptions, and the Effects on Prescribing Habits, https://doi.org/10.1371/journal.pone.0110130
8. De Ferrari A, Gentille C, Davalos L, Huayanay L, Malaga G (2014) Attitudes and Relationship between Physicians and the Pharmaceutical Industry in a Public General Hospital in Lima, Peru. PLoS ONE 6: 9.
9. Ibrahim IAY, Bélanger CH (2015) Pharmaceutical Representatives and Prescription Decisions by Physicians in Saudi Arabia. J Marketing Manag 3: 69-79.
10. McCarthy, E. J. (1964). Basic Marketing, IL: Richard D. Irwin.
11. Negash, Mulugeta and Adamu, Achenif (2017), The Impact of Pharmaceutical Promotion Strategies on Prescribing Behavior of Physicians a Developing Country Experience: Case of Addis Ababa, Ethiopia. Available at SSRN: https://ssrn.com/ abstract=2948208
12. Pinckney RG, Helminski AS, Kennedy AG, Maclean CD, Hurowitz L, et al. (2011) The effect of medication samples on self-reported prescribing practices: a statewide, cross-sectional survey. J Gen Intern Med 26: 40-4.
13. Henderson J, Miller G, Pan Y, Britt H (2008) The effect of advertising in clinical software on general practitioners' prescribing behaviour. Med J Aust 188: 15-20.
14. Gagnon MA, Lexchin J (2008) The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. Plos Medicine 5: 0029-0033.
15. Oshikoya KA, Oreagba I, Adeyemi O (2011) Sources of drug information and their influence on the prescribing behavior of doctors in a teaching hospital in Ibadan, Nigeria. Pan Afr Med J 9: 13.
16. Wang Y, Adelman RA (2009) A study of interactions between pharmaceutical representatives and ophthalmology trainees. Am J Ophthalmol 148: 619-22.
17. Chew LD, O’Young TS, Hazlet TK, Bradley KA, Maynard C. A physician’s survey of the effect of drug sample availability on physicians’ behaviour. J Gen Intern Med. 2000; 15: 478-483.
18. Madhavan S, Amonkar MM, Elliott D, Burke K, Gore JP. The gift relationship between pharmaceutical companies and physicians: An exploratory survey of physicians. J Clin Pharm Ther. 1997; 22: 207-215.
19. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical drug representatives. JAMA. 1995; 273: 1296-1298.